HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship between glycemic control and orthostatic hypotension in type 2 diabetes mellitus--a survey by the Fukuoka Diabetes Clinic Group.

Abstract
We examined the prevalence of orthostatic hypotension and its association with glycemic control, as assessed by hemoglobin A1 (HbA1) concentration, in type 2 diabetic patients. The prevalence of orthostatic hypotension in 886 diabetics who were referred to our study and in 587 diabetics who were not given any antihypertensive drugs was 7% and 6%, respectively. The relationship between orthostatic hypotension and HbA1 levels was evaluated only in subjects not receiving antihypertensive drugs, since antihypertensive agents might induce orthostatic hypotension. HbA1 levels were 11.0 +/- 2.1% in the diabetic patients with orthostatic hypotension, which was significantly higher than the HbA1 levels of 9.9 +/- 2.2% in the diabetic patients without orthostatic hypotension. Multivariate analysis also revealed that the association remained significant after adjustment for the treatment and duration of diabetes, age, sex and body mass index. These findings suggest that glycemic control contributes to the development of orthostatic hypotension in type 2 diabetic patients.
AuthorsN Tsutsu, K Nunoi, Y Yokomizo, M Kikuchi, M Fujishima
JournalDiabetes research and clinical practice (Diabetes Res Clin Pract) Vol. 8 Issue 2 Pg. 115-23 (Jan 1990) ISSN: 0168-8227 [Print] Ireland
PMID2307091 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Glycated Hemoglobin A
Topics
  • Analysis of Variance
  • Antihypertensive Agents (therapeutic use)
  • Blood Pressure
  • Diabetes Mellitus, Type 2 (blood, complications, physiopathology)
  • Female
  • Glycated Hemoglobin (analysis)
  • Humans
  • Hypertension (complications, drug therapy)
  • Hypotension, Orthostatic (blood, physiopathology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: